Moreover, the Tumor Immune Dysfunction and Exclusion (TIDE) analysis further showed that the group with a high level of ARHGAP11A had a higher dysfunction score, but not exclusion score for T cells (Figure 6K and Figure S2F). This evidence concerns the gene ARHGAP11A and neoplasm.